Charles Schwab Investment Management Inc Keros Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 207,758 shares of KROS stock, worth $9.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,758

Previous 181,578 14.42%

Holding current value

$9.49 Million

Previous $7.22 Million 90.51%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$41.26 - $70.48 $1.08 Million - $1.85 Million	26,180 Added 14.42%	207,758 $13.8 Million
Q4 2023 Feb 06, 2024	BUY	$27.12 - $41.05 $125,430 - $189,856	4,625 Added 2.61%	181,578 $7.22 Million
Q3 2023 Nov 08, 2023	BUY	$31.57 - $43.02 $920,833 - $1.25 Million	29,168 Added 19.74%	176,953 $5.64 Million
Q2 2023 Aug 09, 2023	BUY	$37.26 - $51.01 $559,533 - $766,017	15,017 Added 11.31%	147,785 $5.94 Million
Q1 2023 May 11, 2023	SELL	$41.44 - $59.32 $24,200 - $34,642	-584 Reduced 0.44%	132,768 $5.67 Million

Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $443,260 - $581,687	11,236 Added 9.2%	133,352 $6.4 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $554,359 - $800,032	19,941 Added 19.52%	122,116 $4.6 Million
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $37,353 - $96,202	1,435 Added 1.42%	102,175 $2.82 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $101,256 - $142,701	2,404 Added 2.44%	100,740 $5.48 Million
Q4 2021 Feb 11, 2022	SELL	$36.95 - $62.89 $7,685 - $13,081	-208 Reduced 0.21%	98,336 $5.75 Million
Q3 2021 Nov 16, 2021	BUY	$29.27 - $43.71 $584,229 - $872,451	19,960 Added 25.4%	98,544 $3.9 Million
Q2 2021 Aug 16, 2021	BUY	$42.4 - $70.11 $859,617 - $1.42 Million	20,274 Added 34.77%	78,584 $3.34 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $139,158 - $193,996	2,577 Added 4.62%	58,310 $3.59 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $427,824 - $983,282	11,884 Added 27.1%	55,733 $3.93 Million
Q3 2020 Nov 13, 2020	BUY	$27.04 - $62.21 $11,951 - $27,496	442 Added 1.02%	43,849 $1.69 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $871,612 - $1.75 Million	43,407 New	43,407 $1.63 Million

Others Institutions Holding KROS

# of Institutions

153

Shares Held

26.7M

Call Options Held

47.6K

Put Options Held

34.5K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Keros Therapeutics, Inc. Transaction History